glp 1 2025 GLP-1 Drugs: Pulse Survey (U.S.) leading glp-1 medications 2025 GLP-1
Description
Preclinical and translational studies suggest semaglutide may reduce neuroinflammation, promote neurogenesis, and act on the same reward pathways involved in addiction and compulsive behavior
Low blood sugar (hypoglycemia)
That pressure may then trigger inflammation in the gallbladder wall, which is the driver of cholecystitis
This pattern fits with a medication that clears slowly and whose effects wane step by step
Keep in mind that overly aggressive calorie restriction can affect milk supply
